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 Animal studies have shown that behavioral responses to cocaine-related cues are 
altered by serotonergic medications. The effects of pharmacological agents on serotonin 
receptors 2a (5-HT2A) and 2c (5-HT2C), have yielded results suggesting that selective 5-HT2A 
antagonists and 5-HT2C agonists promote the disruption of cocaine-associated memories. One 
measure of cocaine related cues in humans is attentional bias, in which cocaine dependent 
individuals show greater response latency for cocaine related words than neutral words. Data 
from our laboratory shows that cocaine dependent subjects have altered attentional bias 
compared to controls.  
 The purpose of this thesis was to investigate the role of the serotonin system in 
attentional bias and impulsivity in cocaine dependent individuals. We focused on the 
serotonin transporter, serotonin receptors 2A and 2C and tryptophan hydroxylase 1 and 2 
(TPH1 and TPH2). We predicted that attentional bias and impulsivity would be higher in 
cocaine dependent individuals who had lower serotonin function.  
 In the current study, we found a significant association between TPH2 genotype and 
attentional bias for the second block of the cocaine Stroop task. There was also a significant 
association between average attentional bias and HTTLPR genotype in the cocaine 
dependent individuals. The HT2C receptor genotype and attentional bias in our study sample 
also showed a significant difference. We did not find a significant difference between the 
serotonin 2A receptor variants or the TPH1 variants and attentional bias in the cocaine 
dependent group. 
 In conclusion, the current study suggests that serotonergic medications should be 
utilized as pharmacotherapeutic treatment for cocaine addiction. Our results indicate that 
TPH2, the serotonin transporter and 2C receptor should be targeted in such a way as to 
modulate both, leading to increased synaptic serotonin function. 
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1- INTRODUCTION 
 
The definition and public opinion of substance addiction has changed in the last few 
decades. What was once viewed as a problem of will, is now known to be a disease. 
Several systems are thought to be dysfunctional in drug addiction, including inhibitory, 
learning, memory and hormonal systems. As a society, we have come to understand that 
addiction is an important issue facing an alarming number of individuals (Leshner 1997). 
Severe negative consequences of drug abuse and addiction also include indirect 
consequences such as infectious diseases that spread among drug users, crime and 
violence.  
  Many of the changes that result from drug use persist even after the individual ceases 
drug use. These changes might be genetic, molecular or cellular, and in turn lead to 
functional and behavioral changes. When drug-using individuals want to abstain from 
drugs, the major challenges for quitting are likely due to alterations in brain activity, 
receptor sensitization/desensitization and gene regulation.  
Despite the efforts of clinicians and researchers to find an effective way to rescue an 
individual from drug dependence, treatment has not been established. Although early 
pharmacotherapeutic endeavors focused on reversing the illicit drug’s primary effects, 
recently researchers are working on elucidating the neurobiological adaptations that take 
place after chronic abuse (Koob and Volkow 2010). Information on the behavioral, 
genetic and epigenetic changes that result from drug use, is increasingly being utilized in 
the development of treatment.  
Addiction is a disorder which begins with the acute use of a drug and progresses to 
chronic drug-seeking. The term addiction refers to the loss of control over drug use 
despite unwanted consequences (O'Brien, Volkow et al. 2006). Drug addiction develops 
in several stages; initiation of drug use, intermittent to regular use, and, finally, addiction 
and relapse (Kreek, Nielsen et al. 2005). Features of addiction are the development of 
dependence to the drug, which creates a physiological need of the drug for the individual 
to function properly, the development of tolerance, manifested as a need for larger doses 
of the drug to attain the same effect, the development of withdrawal, symptoms that 
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occur when the drug is discontinued, and relapse, which occurs when after a period of 
abstinence, the drug is used again by the drug dependent individual.  
The term drug dependence refers to the physiological adaptation to repeated 
administration of a drug, and occurs with many drugs, but is also the term used to 
clinically diagnose an individual with a substance use disorder (O'Brien, Volkow et al. 
2006). For the purposes of this thesis, the term drug dependent will be used to signify 
both clinical diagnosis using the DSM-IV and the manifestation of the characteristics of 
addiction. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) depicts drug dependence to contain three categories: preoccupation/ 
anticipation, binge/ intoxication, and withdrawal/ negative affect (1994).  
 
Table 1: Criteria for Drug Dependence According to the DSM-IV, people are classified 
as dependent when they show three or more of the following symptoms within one year 
 
A maladaptive pattern of substance use leading to clinically significant 
impairment or distress as manifested by three (or more) of the following, 
occurring at any time in the same 12-month period: 
 
1. tolerance, as defined by either of the following: 
a. a need for markedly increased amounts of the substance to 
achieve intoxication or desired effect 
b. markedly diminished effect with continued use of the same 
amount of the substance 
2. withdrawal, as manifested by either of the following: 
a. the characteristic withdrawal syndrome for the substance  
b. the same (or a closely related) substance is taken to relieve 
or avoid withdrawal symptoms 
3. the substance is often taken in larger amounts or over a longer period 
than was intended 
4. there is a persistent desire or unsuccessful efforts to cut down or 
control substance use 
5. a great deal of time is spent in activates necessary to obtain the 
substance (e.g. visiting multiple doctors or driving long distances), 
use the substance (e.g. chain-smoking), or recover from its effects 
6. important social, occupational, or recreational activities are given up 
or reduced because of substance use 
7. the substance use is continued despite knowledge of having a 
persistent or recurrent physical or psychological problem that is 
likely to have been caused or exacerbated by the substance (e.g., 
current cocaine use despite recognition of cocaine-induced 
depression, or continued drinking despite recognition that an ulcer 
was made worse by alcohol consumption) 
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Drug dependence can also be thought of in terms of changes in neuroadaptive or 
neuroendocrine homeostasis. After a drug is chronically administered, adaptive processes 
to counteract the drug’s effects take place in the central nervous system. During 
withdrawal, these functional neuroadaptive changes are still in place and may produce 
the symptoms experienced during abstinence (such as anxiety, mood dysregulation, and 
somatic abnormalities) and lead to relapse (Koob, Sanna et al. 1998). For example, rats 
exposed to cocaine for 12 hours experience reductions in release of dopamine and 
serotonin in the nucleus accumbens (Weiss, Markou et al. 1992; Weiss, Paulus et al. 
1992). These changes can persist for different periods of time, depending on the length of 
administration (abuse).  
On the other hand, the conditioning theory of drug dependence hypothesizes that in 
individuals who are cocaine dependent, stimuli which have been conditioned with drug 
use can alone produce the desire for cocaine, which can lead to relapse (Weiss, 
Ciccocioppo et al. 2001).  The conditioning theory implies that once the individual is 
exposed to drug-related stimuli in the environment, relapse often follows due to the 
pairing of the rewarding actions of the drug with the previously neutral stimulus. A third 
approach in conceptualizing drug dependence is by depicting it in terms of impulsivity 
and compulsivity (Koob and Volkow 2010). Impulsivity is defined behaviorally as  
 
a predisposition toward rapid, unplanned reactions to internal and external 
stimuli without regard for the negative consequences of these reactions to 
themselves or others (Moeller, Dougherty et al. 2001).  
 
Compulsivity is defined as 
 
elements of behavior that result in perseveration in responding in the face of 
adverse consequences or perseveration in the face of incorrect responses in 
choice situations (Koob and Volkow 2010) .  
 
Koob and Volkow hypothesize that impulsivity is important in the beginning stages 
of drug addiction: during this time reinforcement drives drug seeking and taking. Both 
impulsivity and compulsivity, on the other hand, are important in the later stages: 
negative reinforcement, in this case to avoid an aversive state without the drug on board, 
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drives the same behavior in a compulsive automatic way by this point (Koob and Volkow 
2010). Additionally, Kreek & Nielsen have proposed that impulsivity is important in the 
earlier stages of drug addiction (Kreek, Nielsen et al. 2005). 
In a 2008 US survey, over 700,000 individuals used cocaine for the first time, which 
averages to 2,000 initiates per day, with the average age at first use being 19.8 years 
(SAMHSA 2008) The National Survey on Drug Use and Health revealed that 5.3 million 
Americans aged 12 and older had abused cocaine and 1.1 million had abused crack at 
least once in 2008 (SAMHSA 2008). Substance abuse has been identified as the nation’s 
number one health problem, resulting in more deaths, illnesses, disabilities, and cost to 
society than any other preventable disease (Horgan, Skwara et al. 2001).  Drugs of abuse 
disrupt physiological systems, contributing to drug addiction and relapse. However, we 
are only recently beginning to understand the molecular changes that take place during 
the development of addiction and during withdrawal (Kreek, Bart et al. 2005).  
  
1.1 – NEUROSCIENCE OF COCAINE   
 
Since its synthesis from the coca plant in 1884, cocaine has been medically used as an 
anesthetic, anorectic, cardiovascular stimulant, etc. Recreationally used cocaine can be 
found in three common forms: cocaine hydrochloride salt (powder) or freebase and crack 
rocks which can be smoked (Goldstein, DesLauriers et al. 2009). Cocaine exerts its 
primary effects by blocking neurotransmitter uptake by the dopamine (DAT), serotonin 
(SERT) and norepinephrine (NET) transporters (Uhl, Hall et al. 2002). Cocaine can also 
exert effects on ligand- and voltage-gated channels by blocking these as well (Uhl, Hall 
et al. 2002).  Cocaine non-competitively blocks the uptake of these monoamines by 
binding to a site on the transporter that is different from the substrate binding site 
(McElvain and Schenk 1992). Acute administration of cocaine leads to an increased 
level of serotonin in the medial prefrontal cortex and the hypothalamus (Yang, Bao et al. 
1992). In the dorsal raphe, acute cocaine also suppresses the spontaneous activity of 
serotonin neurons while decreasing the synthesis of serotonin in the striatum, nucleus 
accumbens, and medial prefrontal cortex (Galloway 1990).   
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Chronic doses of cocaine can increase the number of serotonin uptake sites in 
prefrontal cortex and dorsal raphe regions. This in turn can alter the ability of cocaine to 
inhibit the serotonergic activity in dorsal raphe neurons (Cunningham, Paris et al. 1992). 
A study by Egan et al studied the resulting changes of chronic cocaine treatment on 
levels of serotonin (5-HT) and levels of one of its metabolites, 5-hydroxyindoleacetic 
acid (5-HIAA) levels in cortex during periods of withdrawal in rats (Egan, Wing et al. 
1994). Repeated cocaine injections produced a long-term decrease in 5-HT levels in 
frontal cortex regions. There was a relationship between withdrawal time and 5-HT 
levels, with longer withdrawal times producing a greater reduction in 5-HT 
neurotransmission, “suggesting a progressive reduction” (Egan, Wing et al. 1994). When 
cocaine is injected into the ventral tegmental area (VTA), dopamine, norepinephrine and 
serotonin increase in a concentration-dependent fashion (Chen and Reith 1994).    
Cocaine affects several anatomical areas in the brain, including the ventral tegmental 
area, which is important for producing the reinforcing properties of cocaine. The VTA 
receives inputs form the 5-HT system and is innervated by norepinephrine (NE)-
containing neurons. Repeated drug use leads to processes that reverse the resulting 
effects of the drug. When an individual abstains from the drug, the compensatory 
processes that have developed are still active and may be responsible for the negative 
cognitive experience during withdrawal (Winstanley 2007).  
 
 
1.2 – ATTENTIONAL BIAS  
 
Drugs of abuse are salient stimuli that lead to a strong association between drug cues 
and the positive (euphoric) effects of the drug. Substance dependent individuals react to 
these cues when they appear in the environment. For example, when alcohol abusers 
come into contact with something that is reminiscent of an alcoholic beverage (for 
example, seeing a drink or smelling the ethanol) they react to the cue and experience 
physiological arousal and a state termed “craving” (Carter and Tiffany 1999). Craving 
has been defined as a psychological state where the individual feels an obsessive urge to 
repeat drug administration and recapture drug-induced euphoria (Copersino, Serper et al. 
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2004). The expectancies experienced during craving are thought to influence drug-
seeking behaviors. 
Robinson and Berridge synthesized a model where drug-related stimuli attain 
incentive-motivational properties, which in turn changes the way an individual reacts to 
those stimuli. In this model, when an individual repeatedly administers a substance of 
abuse, a neurophysiological response takes place that in turn leads to sensitization with 
each subsequent administration. Cravings for the substance develop after the substance 
has acquired strong motivational properties and obtaining the substance becomes a 
priority (Robinson and Berridge 1993). These incentive-motivational properties take 
place as a result of classical conditioning. When the drug user is administering the drug, 
stimuli or cues in the environment, after one or several pairings with drug use, begin to 
elicit components of the original response that the drug caused. The stimulus from then 
on  
grabs attention, becomes attractive and ‘wanted’ and thus guides behavior to 
the incentive (Robinson and Berridge 1993), p. 261).  
 
Franken extended this model by suggesting when drug-cues are encountered, they 
become the focus of attention. This  increases craving and attention-grabbing properties 
of the stimulus until the substance is acquired and used (Franken 2003).  
Attentional orienting is the  
selective biasing of information processing towards specific attributes of 
events based on changing motivation, volition, or expectation (Lepsien and 
Nobre 2006). 
 
It is hypothesized that a network in the parietal-frontal axis handles information from 
early stages of perceptual analysis using top-down processing (Lepsien and Nobre 2006). 
There are two types of implicit indirect measures of cognitive function used by 
researchers: ones that measure a bias in attention towards stimuli that are related to 
alcohol or drugs and ones that measure implicit memory associations (Wiers, Bartholow 
et al. 2007). Implicit measures provide an automatic measurement of the construct the 
researcher is measuring, which may capture the implicit processes responsible for the 
behaviors in the natural environment (Wiers, Bartholow et al. 2007). One task that 
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measures the extent to which drug related cues direct attention in drug users, or 
attentional bias for a drug stimulus, is the Drug Stroop task (Cox, Fadardi et al. 2006).  
The original Stroop task was constructed to study interference in verbal naming and 
the associated attentional processes (Stroop 1935). The person performing is shown cards 
with words that spell out colors in incongruent ink: for example the word “yellow” in 
green ink or the word “brown” in red ink. In addition to the color words there are also 
rows of Xs which serve as the control stimuli. Stroop and subsequent investigators found 
that it takes subjects longer to name the ink color of the color words than the meaningless 
rows of Xs, and this effect is also observed with words that are related to colors such as 
“sky” and “grass” (Stroop 1935), also reviewed in (Williams, Mathews et al. 1996).  
Williams et al suggest that if the word stimulus semantically activates processing, then 
interference in color naming is likely to take place (Williams, Mathews et al. 1996).  
      Different variations of the Stroop task are widely used to measure attentional bias to 
words or pictures associated with concerns relevant to a subject’s clinical condition (Cox, 
Fadardi et al. 2006). The term bias is used to signify a tendency for an individual to 
allocate more attention to certain stimuli that have become salient (for example drug-
related stimuli). Craving and treatment outcome are also associated with attentional bias 
in drug users (Copersino, Serper et al. 2004; Carpenter, Schreiber et al. 2006; Marissen, 
Franken et al. 2006). The Stroop task, therefore, measures the interference these drug 
stimuli cause on cognitive commands/processes (Vadhan, Carpenter et al. 2007). It 
requires participants to focus on the color of the words or the edge color of pictures while 
inhibiting responses to any other feature that word or picture (Cox, Fadardi et al. 2006).  
This Stroop task has been used to measure the attentional bias of the cocaine-
dependent subjects to stimuli associated with cocaine use. Using two versions of the 
Cocaine Stroop task, Hester and colleagues found that reaction time of cocaine-dependent 
subjects to name the color of cocaine-related words was significantly slower than that of 
neutral words (Hester, Dixon et al. 2006). For one version of the task, which uses pictures 
that are related to cocaine use, evocative (snakes, erotica, mutilated body parts, etc), or 
neutral, cocaine users found the drug-related pictures as distracting as the evocative 
pictures. Vadhan and colleagues reported that a group of treatment-seeking, cocaine-
dependent subjects showed greater interference by cocaine-related words than 
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nontreatment seeking subjects (Vadhan, Carpenter et al. 2007). In a study by Copersino et 
al, three groups of subjects performed the cocaine-word Stroop task: cocaine dependent 
patients, patients with schizophrenia and cocaine dependent patients with comorbid 
schizophrenia (Copersino, Serper et al. 2004).  There was a significant difference 
between reaction time for cocaine words compared to neutral words only in the cocaine 
patient group.     
The above studies suggest that cocaine-related stimuli acquired incentive properties in 
these subjects. In an addiction treatment study, attentional bias to the cocaine-related 
stimuli in the cocaine-dependent subjects was associated with worse treatment outcome 
(Carpenter, Schreiber et al. 2006). Attentional bias was also associated with cocaine 
craving severity ratings (Copersino, Serper et al. 2004). Taken together, these studies 
suggest the experimental utility of investigating attentional bias in cocaine-dependent 
subjects using the cocaine Stroop task.   The Stroop task is thought to detect an alteration 
in attentional processing in which drug-related cues are more salient and therefore 
capture attention better.  
 
1.3 – IMPULSIVITY 
 
Recent models of addiction include the idea that drug users have elevated impulsivity 
and poor inhibitory control due to compromised executive function, which is any higher 
order brain function, usually processed by the frontal lobe (Field and Cox 2008). 
Dysfunction in the prefrontal cortex might result in an inability to inhibit impulses to 
react to increased incentive salience of conditioned drug cues (Dawe, Gullo et al. 2004). 
Impulsivity has also been classified as an endophenotype or vulnerability trait for 
stimulant dependence (Ersche, Turton et al. 2010).  
Impulsive behavior is comprised of several independent dimensions, but some 
commonalties include behavioral disinhibiton, “intolerance of delay to rewards,” quick 
decision making without consideration of consequences, hyperactivity and poor 
attentional ability (Winstanley 2007). Moeller has suggested that impulsivity incorporates 
multiple distinct psychological concepts (Moeller, Barratt et al. 2001). 
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The Barratt Impulsiveness Scale version 11 (BIS-11) is a widely-used questionnaire for 
measuring impulsivity. However, multiple paradigms to measure impulsive behavior in 
both human and non-human subjects are used by investigators. They can be divided into 
two categories: those measuring decision making and those measuring impulsive action 
(Winstanley 2007). 
In addition to the attentional bias for cocaine-related stimuli, cocaine-dependent 
subjects also show other cognitive deficits related to dysfunction of prefrontal cortex such 
as increased trait impulsivity and impaired inhibitory control. Several studies have 
reported that cocaine dependent subjects have significantly higher scores on the BIS-11, 
compared to healthy controls (Moeller, Barratt et al. 2004; Moeller, Hasan et al. 2005).  
Individuals with substance dependence show a variety of impulse control deficits. 
Brain imaging studies have shown that in individuals who have recently stopped using 
drugs, the orbitofrontal cortex is less active (Volkow, Wang et al. 2005). This change in 
cortical activity may be related to the increased levels of impulsivity seen in drug users 
(Volkow, Wang et al. 2005). Abstinent drug using individuals also perform poorly on 
gambling tasks, and made premature-like responses on the immediate and delayed 
memory task (IMT/DMT) (Moeller, Hasan et al. 2005).   
Cocaine-dependent subjects with high impulsivity and poor inhibitory control may 
have difficulty inhibiting their response to cocaine-related stimuli. This relates to 
treatment. In a study by Moeller et al, self-report impulsivity, measured by the Barratt 
Impulsiveness Scale version 11 (BIS-11), was correlated with severity of cocaine use and 
severity of cocaine withdrawal symptoms. The motor impulsivity subscale exhibited the 
highest effect. Also, subjects with high impulsivity at baseline, were more likely to drop 
out of treatment (Moeller, Dougherty et al. 2001).  
 
1.4- SEROTONIN  
 
Serotonin was discovered 60 years ago and is one of the biogenic amine 
neurotransmitters. One of the major neurotransmitters of the nervous systems, serotonin 
is responsible for several regulatory functions such as mood states, food intake, and 
impulsive aggression. In addition to its involvement in the central nervous system, 
10 
 
serotonin also plays a role in cardiovascular, pulmonary, gastrointestinal, and 
genitourinary systems (Kandel 2000). Serotonergic neurons modulate the activity of 
cortical and subcortical neurons in several ways by activating both inhibitory and 
excitatory receptor subtypes (Kandel 2000).   
Cell bodies of serotonergic neurons are concentrated in and around the raphe nuclei 
of the brain stem. The raphe is composed of three nuclei: the dorsal, median, and the 
raphe magnus pallidus. Fibers from neurons in the dorsal raphe innervate dopaminergic 
neurons of the substantia nigra and the ventral tegmental area, influencing the levels of 
dopamine in these regions. Projections from the median raphe go through the stria 
terminalis and fornix to reach the amygdala and hippocampus. Projections also travel to 
cortex, superiar colliculi and cerebellum. Serotonin-containing neurons are also found in 
the hypothalamus, especially at the suprachiasmatic nucleus—an area that regulates 
circadian rhythms which include the sleep-wake cycle. Along with the activity of 
noradrenergic neurons, the activity of serotonergic neurons fluctuates with sleep and 
wakefulness (Nolte 1999). Cells from the caudal raphe nuclei project to the brainstem 
and spinal cord (Nolte 1999). The diverse connectivity of serotonergic neurons allows 
this neurotransmitter system to exert effects on a wide range of anatomical regions.   
 
1.4 – SEROTONIN AND CUE REACTIVITY 
 
Rodent studies have shown that behavioral responses to cocaine-related cues are 
altered by serotonergic medications (Fletcher, Grottick et al. 2002). Cunningham et al 
have investigated the effects of pharmacological agents on serotonin receptors 2A (5-
HT2A) and 2C (5-HT2C), finding that selective 5-HT2A antagonists and 5-HT2C agonists 
promote the disruption of cocaine-associated memories (Nic Dhonnchadha, Fox et al. 
2009).  
One measure of responsivity to cocaine related cues in humans is attentional bias, in 
which cocaine dependent individuals show greater response latency for cocaine related 
words than neutral words. Data from our laboratory and other literature shows that 
cocaine dependent subjects have altered attentional bias compared to controls and this is 
in agreement with other findings (Hester, Dixon et al. 2006; Liu, Lane et al. 2011). Since 
11 
 
serotonergic medications alter behavioral responses to cocaine related stimuli in rodents, 
it is possible that polymorphisms which were found to be associated with alterations in 
the serotonergic system could also affect behavioral responses to cocaine related cues in 
humans.  
Serotonin synthesis involves several steps and is highly regulated. Serotonin and the 
essential amino acid tryptophan from which it is derived, are both indoles (aromatic 
compounds), with a five member ring that has nitrogen joined to a benzene (Lodish 
2008). Two enzymes are needed to synthesize serotonin: tryptophan hydroxylase, an 
oxidase similar to tyrosine hydroxylase and aromatic amino acid decarboxylase (AAAD) 
(Kandel 2000). Tryptophan hydroxylase (TPH) is the rate-limiting enzyme responsible 
for the synthesis of 5-HT. After tryptophan (an essential amino acid) is hydroxylated, 5-
hydroxytryptophan decarboxylase catalyzes the final step to result in serotonin, or 5-
hydroxytryptamine (5-HT) (Nolte 1999).  
There are 14 known subtypes of serotonin receptors, classified into seven families. 
The 5-HT3 receptor is ionotropic, while the rest are metabotropic. The metabotropic 
receptors are G-protein-coupled receptors (GPCRs) and have seven transmembrane 
domains. The GPCRs are categorized into four groups based on their main second 
messenger system: the 5-HT1-family of receptors uses Gαi/Gαo proteins while the 5-HT2 
family couples Gαq proteins. The 5-HT4, 5-HT6, and 5-HT7 receptors use Gs proteins and 
the 5-HT5 receptors are unknown (Raymond, Mukhin et al. 2001). 
The limbic system is dense in 5-HT1A receptors, with the auto-receptors being 
localized in the cell bodies and dendrites of the dorsal and median raphe nuclei (Riad, 
Garcia et al. 2000; Lanfumey and Hamon 2004). In the hippocampal area, these receptors 
are found post-synaptically and are negatively coupled to adenylyl cyclase (AC) via Gαi 
and/or Gαo proteins (De Vivo and Maayani 1986; Weiss, Sebben et al. 1986). 5-HT1A 
receptors inhibit neuronal firing through activation of G-protein-gated inwardly rectifying 
potassium (GIRK) currents and inhibition of Ca2+ channels (Oleskevich 1995; Sodickson 
and Bean 1998).   
For the purpose of this thesis, I will focus on the 5-HT2A and 5-HT2C receptors. The 
5-HT2A receptors are abundant in prefrontal cortex (Miner, Backstrom et al. 2003). It is 
the site of action of many illicit and pharmacological substances, for example, LSD and 
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atypical anti-psychotics (Aghajanian and Marek 1999). These receptors have been 
characterized by immunohistochemical techniques to the apical dendrite shafts, proximal 
to the pyramidal cell soma (Jakab and Goldman-Rakic 1998).  
The HT2C receptors are densely expressed in regions implicated in anxiety, mood, 
drug-induced hallucinogenesis, reward, neuroendocrine regulation and appetite (Roth, 
Berry et al. 1998). They couple to the Gq family of G proteins, activating phospholipase 
C to hydrolyze phosphoinositide and produce two second messengers, diacylglycerol and 
inositol triphosphate (Roth, Berry et al. 1998). Inositol triphosphate mobilizes calcium 
from intracellular stores, increasing the intracellular calcium consentration while 
diacylglycerol activates protein kinase C. A study that administered the 5-HT2C agonist 
m-chlorophenylpiperazine (m-CPP) showed that compared to healthy volunteers, patients 
with alcoholism, anxiety disorders or affective disorders had differences in hormonal and 
psychological responses after administration of m-CPP (Charney, Woods et al. 1987; 
Joseph-Vanderpool, Jacobsen et al. 1993).  
The goal of this thesis is to determine whether attentional bias to cocaine related 
stimuli in cocaine dependent subjects is associated with functional polymorphisms of the 
serotonin transporter promoter polymorphic region (5-HTTLPR) of the serotonin 
transporter gene (SLC6A4), which has been shown to affect serotonin transporter 
expression (Hu, Lipsky et al. 2006). Additionally, we will examine the association 
between attentional bias and two serotonin receptor polymorphisms, one in the 5-HT2A 
and the other in the 5-HT2C receptors. The functional 5-HT2A T102C polymorphism 
(rs6311) has been reported to modulate transcriptional activity and the 5-HT2C Cys23Ser 
polymorphism (rs6318) has been reported to alter receptor function (Polesskaya and 
Sokolov 2002; Okada, Northup et al. 2004)  
 
Serotonin transporter SLC6A4 gene:   
 
The serotonin transporter (5-HTT), encoded by the SLC6A4 gene and located at 
17q11.2, codes for a central regulator of serotonin turnover, transporting serotonin from 
the synaptic cleft into the presynaptic neuron; terminating serotonin’s action. A 20-23 
base pair repeat polymorphism in the SLC6A4 promoter (termed 5-HTTLPR) has been 
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shown to affect transcriptional activity of this gene.  The short or “S” allele with 14 
repeats was shown to have lowered transcriptional activity than that the long or “L” allele 
with 16 repeats (Heils, Teufel et al. 1996; Lesch, Bengel et al. 1996; Heils, Mossner et al. 
1997).This repeat polymorphism was found to be associated with anxiety-related traits 
and depression (Lesch, Bengel et al. 1996). Recently, a single nucleotide polymorphism 
(SNP) (A/G) rs25531, was identified in the repeat sequence of the L-allele that 
subdivided the polymorphism further into the LA and LG alleles (Hu, Lipsky et al. 2006).  
The LG and S alleles were found to have similar low expression levels.  This allows the 
genotypes to be classified as having high (LA/LA), or low (LA/LG, S/LG, LG/LG, S/S) 
transcriptional efficacy. The SA allele is very rare and was not present in our study 
sample (Wendland, Martin et al. 2006). More than 20 studies have examined the 
relationship of SLC6A4 variants and response to antidepressant treatment [reviewed in 
(Horstmann and Binder 2009)].  A meta-analysis of 1400 subjects of different ethnicities 
from 15 studies reported diminished response to antidepressant therapy in S-allele 
carriers (Serretti, Kato et al. 2007).  A more recent meta-analysis found evidence that 5-
HTTLPR S allele moderates the relationship between stress exposure and development of 
clinical depression (Karg, Burmeister et al. 2011). Chronic treatment with cocaine in 
vitro causes enhanced surface expression of the serotonin transporter in cells, while post-
mortem studies have revealed an up-regulation of 5-HTT by cocaine (Little, Kirkman et 
al. 1993; Kittler, Lau et al. 2010).  
Even though the internal SNP was identified some time ago, and shown to affect the 
functionality of the 5-HTT, many subsequent studies only genotype for the bi-allelic 
version of the 5-HTTLPR. In the present study, we analyzed our data both ways.  
 
Serotonin receptor 2A HTR2A gene: 
 
The 5-HT2A receptor is encoded by the 5-HTR2A gene located at 13q14.2.  Several 
common SNPs in the 5-HTR2A gene have been identified and studied: rs6311 (-
1438A/G), and rs6312 (-783A/G) in the 5’ upstream region, rs6313 (102T/C, Ser34Ser) 
and rs6314 (1354C/T, His452Tyr) in the coding region, and rs7997012 in the second 
intron of 5-HTR2A.  The variants rs6311 (-1438A/G) and rs6313 (102T/C) are reported to 
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be in linkage disequilibrium and rs6311 (-1438A/G) is located upstream of two 
alternative promoters for HTR2A (Peacock, Warren et al. 1993; Spurlock, Heils et al. 
1998).  Allele specific expression analysis has shown that the T allele of rs6313 (102T/C) 
was expressed at a higher level than the C allele in post-mortem schizophrenic brain 
tissues (Polesskaya and Sokolov 2002).  The same type of analysis found that the 102C 
allele was expressed at lower levels that the 102T allele in brain tissue, but not in 
lymphocytes (Fukuda, Koga et al. 2006).  Other studies have not found any differences in 
allele specific expression for the 102T and 102C alleles (Bray, Buckland et al. 2004; De 
Luca, Likhodi et al. 2007).   
It has been reported that the HTR2A gene is imprinted, and is expressed only from the 
maternally derived allele (Kato, Shimizu et al. 1996; Kato, Ikawa et al. 1998).  Another 
study however reported monoallelic expression of HTR2A in brain tissue in only 4 of 18 
subjects (Bunzel, Blumcke et al. 1998).  Both the -1438A/G and the 102C/T variants 
create CpG dinucleotide sites, which, have been reported to be methylated at high levels 
and HTR2A expression was positively correlated with C-methylation of the -1438 CpG 
site (Polesskaya, Aston et al. 2006).  The -1438A/G variant has been shown to be 
associated with response to treatment with citalopram for major depressive disorder in a 
Korean population (Choi, Kang et al. 2005).   
 
Serotonin receptor 2C HTR2C gene: 
 
The serotonin receptor 2C is encoded by the HTR2C gene located on the X 
chromosome. A polymorphism at position 23 leads to a cysteine to serine change 
(Lappalainen, Zhang et al. 1995). The substituted amino acid is on the extracellular N-
terminus of the 5-HT2C receptor. Cysteine is involved in a disulfide bridge formed within 
G-protein coupled receptors (GPCRs). The cysteine at position 23 is the only cysteine 
residue in the HTR2C gene. It is hypothesized that the serine substitution disrupts 
disulfite bond formation within these receptors (Okada, Northup et al. 2004). Also, the 
N-terminal region of the 5-HT2C receptor has an extra hydrophobic region which may be 
disrupted by the substitution and may affect the receptor’s function (Hurley, Bloem et al. 
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1999). Because this receptor is located on the X-chromosome, there’s the possibility for 
chimeric expression in females due to X-inactivation.  
Okada and colleagues investigated whether Cys23Ser affects ligand affinity, 
transduction and constitutive activity of the 5-HT2C receptor. The two alleles were 
compared after expression in COS-7 (kidney) cells. Their results demonstrated that this 
variant is functional. The serine substitution led to a constitutively more active receptor. 
While the results suggested that there may not be a difference between the two alleles 
when the receptor is uncoupled and inactive and the variant may not cause a change in 
affinity for G proteins or G protein activity when serotonin is present in excess, it can 
activate Gq to a higher degree in the absence of 5-HT, suggesting that it is constitutively 
more active (Okada, Northup et al. 2004). Constitutive activity is related to receptor 
desensitization, meaning constitutively active 5-HT2C receptors are thought to be 
constitutively desensitized (Westphal, Backstrom et al. 1995).  
 
Tryptophan Hydroxylase 1 and 2 TPH1 and TPH2 genes 
 
Tryptophan hydroxylase is the rate limiting enzyme in serotonin synthesis (Koe and 
Weissman 1966; Jequier, Lovenberg et al. 1967). There are two forms of tryptophan 
hydroxylase, tryptophan hydroxylase (TPH1) which is a peripheral subtype (McKinney, 
Knappskog et al. 2005) and tryptophan hydroxylase 2 (TPH2) which is the neuronal 
subtype (Walther and Bader 2003). TPH1 and TPH2 are highly homologous and share 
key structural sequences for enzyme activity. Both TPH1 and TPH2 are expressed in the 
human central nervous system, including anatomical regions such as the cortex, 
hypothalamus, thalamus, hippocampus, amygdala, cerebellum and raphe nuclei (Zill, 
Buttner et al. 2007; Saetre, Lundmark et al. 2010). TPH1 was identified and 
characterized first, and is found in the enterochromaffin cells of the gut and in the pineal 
gland (Zhang et al, 2006). TPH2 is expressed predominately in the cells in the raphe 
nuclei and in peripheral enteric neurons in the gut (Cote, Thevenot et al. 2003; Walther, 
Peter et al. 2003).  
The gene that encodes TPH1 is located on chromosome 11 in region 11p15.3-p14 
(Craig, Boularand et al. 1991). Many variants have been identified in the gene, with 
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several associations found relating TPH1 and alcoholism, nicotine dependence, antisocial 
behavior and heroin addiction (Nielsen, Goldman et al. 1994; New, Gelernter et al. 1998; 
New, Gelernter et al. 1998; Nielsen, Barral et al. 2008), reviewed in (Yuferov, Levran et 
al. 2010).  
Variants in the TPH2 gene were studied and identified by Nielsen and colleagues 
(Nielsen, Barral et al. 2008). The researchers resequenced the TPH2 gene and identified 
both new and previously identified variants in individuals with addictive diseases and 
healthy volunteers. They looked for associations using the TPH2 variants and the 
previously well-studied TPH1 rs1799913 variant. There was a significant interaction 
between the TPH1 variant and TPH2 rs4290270 variant in heroin addicted Hispanic 
individuals. Based on these findings, in the present study we focused on these two 
polymorphisms of the two TPH genes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 – HYPOTHESIZED MOD
 
Figure 1: Proposed model for the role of the serotonergic system
A) The different steps in the serotonin pathway are depicted by synthesis (1), removal of 
neurotransmitter from the synapse (2) and continuation 
post-synaptic or receiving neuron (3).
 
Figure 2: Proposed model after chronic cocaine exposure
hypothesized through reduced expression of the TPH1 and TPH2 genes 
removing released serotonin from the synapse at a higher rate 
such as sensitization or desensitization for the 5
 
 
EL   
 
 in attentional bias and impulsivity. 
of neurotransmission by the receptors in the 
  
 
. A decrease in production of serotonin is 
(1), increased 5
(2),and changes in receptor function 
-HT2A and 5-HT2C receptors (3).   
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There are four major processes that regulate serotonin system activity: 1) synthesis of the 
molecule which involves tryptophan hydroxylase 2) removal of the neurotransmitter by 
several key players, the serotonin transporter and breakdown by monoamine oxidase and L-
aromatic amino acid decarboxylase, and 3) perpetuation of neuronal signaling through 
various serotonin receptors. The serotonergic system is a primary target of cocaine. After 
cocaine binds the serotonin transporter, the homeostasis of the system is perturbed, leading to 
changes that bring the neurotransmitter function back to baseline. There is evidence for 
crosstalk between different stages of serotonin function and transmission. For example, the 
serotonin 1A receptors are involved in feedback regulation of the serotonin system (Popova, 
Naumenko et al. 2010). These receptors are expressed both presynaptically and 
postsynaptically and are able to change the firing rate of the neuron, and therefore serotonin 
release (Barnes and Sharp 1999; Popova, Naumenko et al. 2010). Acute treatment with a 5-
HT1A agonist was shown to cause desensitization of 5-HT2A receptors (Carrasco, Van de Kar 
et al. 2007). In another experiment, when rats were treated with a 5-HT1A receptor agonist, a 
reduction in 5HT1A mRNA levels, 5-HT2A mRNA levels in frontal cortex and hippocampus, 
and TPH2 mRNA levels in the midbrain (Popova, Naumenko et al. 2010) . Perturbations in 
the serotonin system are also able to cause changes in other neurotransmitter systems. 
We hypothesize that chronic cocaine exposure leads to reduced function of the serotonin 
transporter, 5-HT2A and 5-HT2C receptors and TPH1 and TPH2 in cocaine dependent 
individuals. We expect individuals who carry these variants in these genes that lead to an even 
further reduction in serotonin levels at the synapse (for example, individuals with the less 
receptors or more transporter expressed in their system) will be the ones that show more 
attentional bias for cocaine-cues and higher impulsivity (see specific aims below).  
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3 -  SPECIFIC AIMS   
 
Specific Aim 1: To examine the relationship between genotype of the serotonin 
transporter insertion/deletion polymorphism (5-HTTLPR) and attentional bias in cocaine 
users and healthy controls. We hypothesize that cocaine users will show more attentional 
bias to cocaine related stimuli and that this higher attentional bias will be associated with 
the long (higher expressing, L) form of the serotonin transporter, which has been shown 
to reduce serotonin levels at the synapse. We expect cocaine users that are homozygous 
for the higher activity (L) form of the transporter to display a higher attentional bias in 
the cue reactivity task. 
 
Subaim 1a: To examine the relationship between genotype of the serotonin 
transporter insertion/deletion polymorphism and impulsivity in cocaine users and 
healthy controls.  
 
Specific Aim 2: To examine the relationship between HTR2A and HTR2C 
polymorphisms and attentional bias in cocaine dependent subjects. Pharmacological 
agents for the 5-HT2A and 5-HT2C receptors have been shown to differentially affect 
cocaine-cue related memories, specifically 5-HT2A receptor antagonists and 5-HT2C 
receptor agonists reduce responses to cocaine cues in rats (Liu and Cunningham 2006; 
Nic Dhonnchadha, Fox et al. 2009). Therefore, we will genotype cocaine-dependent 
subjects for HTR2A and HTR2C receptor polymorphisms. We hypothesize that the T 
allele of the HTR2A polymorphism (rs6313), which leads to increased receptor 
expression, and the Ser allele of the HTR2C polymorphism (rs6318), which leads to less 
transcriptional activity, will both be associated with increased attentional bias.  
 
Subaim 2a:  To examine the relationship between HTR2A and HTR2C 
polymorphisms and impulsivity in cocaine dependent subjects. 
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4– METHODS  
 
4.1 SUBJECTS 
 
Fifty cocaine dependent and 20 healthy volunteer human participants were recruited 
through local newspaper advertisements in Houston. The cocaine dependent subjects 
were recruited using the Treatment Research Clinic of the Center for Neurobehavioral 
Research on Addictions within the UT Health Science Center. After an initial phone-
interview screening, interested subjects had a first intake appointment where they signed 
an informed consent form, received a medical evaluation, completed various self-report 
neuropsychiatric questionnaires and had blood samples collected.  
Inclusion criteria for cocaine dependent subjects were: age of at least 18 years, and 
meeting current DSM-IV criteria for cocaine dependence. If the subjects had current 
DSM-IV Axis I disorder other than substance abuse/dependence, a current diagnosis of 
other substance dependence besides cocaine, any serious non-psychiatric medical illness 
requiring ongoing medical treatment or which could affect the central nervous system, 
concomitant use of prescription medications that could affect the central nervous system, 
or active suicidal ideation, they were excluded from the study. Subjects were not 
excluded if they met criteria for alcohol or marijuana abuse.  
For control subjects inclusion criteria were age of at least 18 years, and not meeting 
current or past DSM-IV criteria for any Axis 1 disorder. Exclusion criteria for control 
subjects included the same criteria as the cocaine subjects as well as any current or past 
substance abuse or dependence, any non-psychiatric or medical illness needing medical 
treatment or which might affect the nervous system, and a positive HIV test. Subjects 
were also excluded if they were experiencing suicidal ideation or scored greater than 15 
on the Hamilton Depression and Anxiety Scale (Hamilton 1960). For female subjects, a 
positive pregnancy test or breast feeding were also exclusion criteria.  
 
 
4.2 – BEHAVIORAL TASK  
 
 Figure 3: The Cocaine Stroop Task
different colored ink. There were 4 categories of word
environmental, neutral furniture, neutral salient and cocaine
 
The Cocaine Stroop task was designed to measure attentional bias to cocaine
stimuli (Hester, Dixon et al. 2006; Vadhan, Carpenter et al. 2007)
participant is presented with words printed in color, and asked to name the color of each 
stimulus by pressing mouse buttons covered by colored sticker
in size 18) appeared in red, blue or green font color against a b
stimulus words were cocaine
while others were neutral words (for example “Sofa
 
 
. Depicted above is a representational diagram of words in 
s presented to subjects in the task: neutral 
-related.  
. In this task, the 
s. The words (bold Arial font 
lack background.  The 
-related (for example “Crack” “Rocks,” “High,” “Dealer,” etc) 
,” “Oven,” “Cabinet,” “Window,” etc). 
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 Figure 4: Diagram of stimulus presentation in 
  
The participant was instructed to ignore the meaning of the words, and concentrate 
only on naming the color in which the word is written as quickly and as accurately as 
possible. A short beep sound was made for incorrect responses. 
for 60 trials. Subsequently, f
After the practice trials, one block of stimulus (cocaine) words, and three blocks of the 
neutral words were presented and this was repeated in random order. 
scored as the mean cocaine reaction time minus the mean control reaction time.
stimulus was displayed on the
milliseconds (ms) passed. 
inter-trial interval.  
 
 
4.3 – IMPULSIVITY MEASURE 
 
 
the Cocaine Stroop task.  
Each subject practiced 
our blocks of words were presented in two parts for the task
Attenti
 screen until the subject responded or until 1800 
A blank screen was presented for 500 ms and this was the 
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Subjects completed the Barratt Impulsiveness Scale. (BIS-11), the most widely used 
self-report measure for impulsivity (Patton, Stanford et al. 1995). The BIS-11 is a 30 item 
questionnaire which has been used in several previous studies on impulsivity and aggression 
(Allen et al. 1998b; Cherek et al. 1997). Each item in the questionnaire is rated from 1 to 4, 
and 3 subscales were determined by factor analysis: motor, attentional and nonplanning 
impulsiveness (Patton, Stanford et al. 1995; Stanford, Anderson et al. 2009).  Items in the 
questionnaire include statements such as “I plan tasks carefully”, “I get easily bored when 
solving thought problems”, “I change residences”, “I am restless at the theatre or lectures”, 
etc. Subjects are instructed to answer quickly and honestly and rate each statement by 
marking one of the following options: Rarely/ Never, Occassionally, Often and Almost 
Always/ Always.   
 
4.4- DNA SAMPLE COLLECTION  
 
Blood samples were collected by a phlebotomist into an 8 ml EDTA tube. The tube 
was placed in a centrifuge and centrifuged at ~1500-2000 X g for 10-15 min at room 
temperature. Using a transfer pipet, the plasma, buffy coat, and red blood cell layers were 
removed and placed in separate cryostorage tubes and banked at -80 degrees.  DNA was 
isolated from the buffy coat layer of blood samples using the Qiagen PureGene kit 
(Valencia, CA). After purification, DNA quality was measured using a NanoDrop 
(Wilmington, Delaware). Some samples were run on E-gels to make sure there was no 
degradation of the isolated DNA.  
 
4.5 – GENOTYPING THE 5-HTT 
 
We performed fragment analyses for the two insertion/deletions that are commonly 
found in the serotonin transporter SLC6A4 gene: 5-HTTLPR and STIn2. The promoter 
polymorphism 5-HTTLPR was genotyped for the repeat polymorphism and the internal SNP 
rs25531, to determine the trialleic LA, LG and S serotonin transporter promoter alleles. The 
high expressing LA allele was designated L' and the low expressing LG and S alleles were 
grouped as S'.  
Primers were designed using 
ordered from the Midland Certified Reagent Company
used were 5' GCAACCTCCCAGCAACTCCCTGTA 3
GAGGTGCAGGGGGATGCTGGAA 3
was amplified using p
of  18.9 µL H20, 2.5 µ
, 1 µL of 50 mM MgSO
reverse primers, 100 ng DNA and 0.1 
Polymerase.  The total volume for each sample was 25uL. The sequence was: 1 cycle: 
94°C @ 1 min; 30 cycles: 94°C @
cycle: 72°C @ 5 min. 
To differentiate between the two forms of the L allele
product was subsequently digested with 
Biolabs, Ipswich, MA
allele present. All digested PCR product samples were run on 
gels (Bio-Rad, Hercules, CA) 
(Invitrogen) at 150 volts for 1 hour, stained
UV light using the Gel DockIt imager
genotypes depicted on
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Genotyping method for 5
digested with HpaII enzyme, which cut 
If the G allele was present, this led to two small bands on the gel, as depicted above. 
 
Vector NTI (Invitrogen, Carlsbad, CA
 (Midland, Texas)
' and 5' 
' (Hu, Oroszi et al. 2005). The 
olymerase chain reaction (PCR). The PCR mix was comprised 
L Invitrogen High Fidelity Buffer,  2.5 µl of 10 mM dNTP  mix 
4, 0.5 µL of 25 µM concentration of  both the forward and 
µL of Invitrogen Platinum High Fidelity Taq 
 30 sec; 60°C @ 30 sec, 72°C @ 30 sec; and 1 
 
, 5 µL of the
HpaII restriction enzyme (New England 
), which cleaves the PCR product at rs25531when there is a G 
precast 
in 1 % Tris/Borate/EDTA (TBE) buffer solution 
 with ethidium bromide and imaged with 
 (UVP, Upland, CA). Two people confirmed the 
 the gels.  
-HTTLPR. After PCR amplification, each sample was 
if there was a G present in the amplified gene product. 
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4.6 - Genotyping TPH1 and TPH2  
 
Genotypes were determined by a 5'-exonuclease fluorescence assay (TaqMan) using 
pre-designed TaqMan (Applied Biosystems, Foster City, CA) primer-probe sets (Assay ID 
C_2645661_10 for TPH1 variant rs1799913 and C_26385365_10 for TPH2 variant 
rs4290270) and analyzed on an ABI Prism 7900 (Applied Biosystems, Foster City, CA) as 
previously described (Whitcombe, Brownie et al. 1998; Ranade, Chang et al. 2001). PCR 
cycling was performed by incubation at 50ºC for 2 min and at 95ºC for 10 min followed by 
40 cycles at 95ºC for 15 s and 62ºC for 1 min. Upon completion of PCR cycling, genotype 
analysis was performed on the ABI Prism_ 7900 sequence detection system using SDS 2.2 
software (Applied Biosystems, Foster City, CA). All genotype analyses were performed 
during a time when the clinical status of the subjects was still blinded.  TaqMan assays were 
performed in duplicate. We did not observe any inconsistencies between duplicate runs.  
 
4.7- Genotyping the HTR2A and the HTR2C receptor variants 
 
Genotypes for HTR2A and HTR2C were also determined by a 5'-exonuclease 
fluorescence assay (TaqMan) using pre-designed TaqMan (Applied Biosystems, Foster 
City, CA) primer-probe sets two variants in the HTR2A gene: rs6311 (Applied Biosystems, 
Assay ID C_3042197_1_) and rs6318 (Assay ID C_2270166_10) on an ABI Prism 7900 
(Applied Biosystems, Foster City, CA). PCR cycling was performed by incubation  at 50ºC 
for 2 min and at 95ºC for 10 min followed by 40 cycles at 95ºC for 15 s and 62ºC for 1 min. 
Genotype of the PCR products was analyzed using the ABI Prism 7900 sequence detection 
system using SDS 2.2 software (Applied Biosystems, Foster City, CA). All genotype 
analyses were performed during a time when the clinical status of the subjects was still 
blinded.  Again, assays were performed in duplicate and we observed no inconsistent results 
between duplicate plates.   
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Figure 6: Genotyping method for TaqMan assays. After PCR amplification, each sample was 
analyzed using an ABI fluorescence reader. The allelic discrimination plot above shows the 
homozygotes for the first allele close to the X-axis (red) and the homozygotes for the 
second allele in the Y-axis (blue). The heterozygotes are depicted in the middle and the 
black X’s are negative control samples.  
 
4.8 - Statistical analysis 
 
All variants were tested in the control group for Hardy Weinberg equilibrium. A p 
value of less than 0.05 was considered significant. The data was analyzed using several 
grouping methods. First we focused on only African American subjects, or all individuals 
combined. For both these large groups we examined cocaine users and control subjects 
together, only the cocaine users or only the control subjects. Within these groups, we either 
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did not control for any other variables, controlled for age and gender or controlled for age, 
gender and diagnosis.  
Allelic and genotypic analyses were performed for the HTR2A, TPH1 and TPH2 genes. 
For the 5-HTTLPR, we analyzed genotype and allele frequencies and also grouped genotype 
analysis for LL vs. S carriers. In addition to this, we also analyzed the 5-HTTLPR data as 
others have done in the past, without accounting for the internal SNP (simply L or S, 
ignoring that LG is transcriptionally similar to S) in order to determine if there was a 
difference between the methods.  
For the HTR2C, the analysis was different because this gene is on the X-chromosome. 
We analyzed the HTR2C data assuming men are homozygotes (looked at both genotypic and 
allelic information), focusing on the presence of the C allele, or focusing on the presence of 
the G allele.  
Analysis of variance, Pearson Chi Square tests and Fischer’s Exact tests were 
performed for genotype and allele frequency data for all genes with regard to group (cocaine 
or control.) We tested for Hardy-Weinberg Equilibrium in the control groups. None of the 
groups violated Hardy-Weinberg Equilibrium for any of the genes. The sample was 
analyzed as both ethnically heterogeneous and ethnically homogenous groups. African 
Americans comprised the largest group within the sample and were therefore analyzed 
separately. One way ANOVA tests were performed to determine significance of the 
association between genotypes or allele frequencies and attentional bias. We used a two way 
ANOVA test to examine if there were interactions between variables.  
Power analyses was performed using the G*Program. Calculations were performed 
using the post-hoc option in the G*Power Program.   
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5– Results 
 
All genes studied did not violate Hardy-Weinberg equilibrium in the control 
groups. The largest ethnic group in our sample was African Americans. To avoid bias 
due to population stratification, we analyzed the African American cocaine dependent 
subjects separately.  
In our study sample, there was a significant difference in age and gender ratio 
between the cocaine dependent and healthy control groups, with the cocaine 
dependent group being significantly older (p < 0.001) and having significantly fewer 
women than the control group (p = 0.003) (refer to Table 1 below).  
 
 
Control Cocaine  
Age * 31 ± 9 46 ± 8 
Gender** 
10 F 
10 M 
8 F 
42 M 
        Ethnicity 
16 African 
American 
34 African 
American 
 
2 Asian 
1 Caucasian 
1 Hispanic 
13 Caucasian 
2 Hispanic 
1 Other 
 
Table 2: Demographical Information and differences between groups. Age was significantly 
different between control and cocaine groups (* t = 7.07, p < 0.001), as well as the male to 
female ratio (** Χ2 = 8.65, p = 0.003).  
 
Our study aimed to determine which cocaine dependent individuals exhibited 
the highest attentional bias in the cocaine Stroop task. We analyzed the behavioral 
data by grouping all cocaine subjects and comparing the average score for the whole 
task and comparing it to control subjects. Overall, cocaine dependent individuals had 
significantly higher attentional bias scores than control subjects (p = 0.01). When we 
analyzed the Cocaine Stroop task by blocks, 
attentional bias scores for the first block of the task (first 120 stimuli) than the second 
block. The scores between both blocks were s
correlation = 0.40, p <0.001) 
had higher scores) was consistent between blocks. 
cocaine dependent subjects scored significantly higher
0.01 AA subjects only)
control groups was not significant for the second block
 
 
Figure 7: Stroop Task 
controls. There was a decrease
task (green bar) of the Cocaine Stroop Task. 
 
We administered the BIS
associated with serotonergic gene variants. We hypothesized that higher impulsivity 
would be observed in the cocaine dependent subject, a finding that has been 
consistently reported in the literature. C
report impulsivity in the t
controls (p < 0.001). For the entire group of subjects, c
displayed higher self-
motor impulsivity (p = 0.003) 
scores of the BIS-11. 
 
both groups of subjects displayed higher 
ignificantly correlated (
however, and the direction (cocaine dependent group 
For the first block of the task, the 
 (p = 0.003 all ethnicities; p = 
. The difference in attentional bias between cocaine and 
 (see Figure 7 
Results: cocaine dependent subjects had more attentional bias than 
 in attentional bias for both groups in the second block of the 
 
-11 to subjects to see if higher impulsivity was 
ocaine dependent subjects had higher self
otal scores of the BIS-11 compared to non-drug using 
ocaine-dependent subjects also 
report impulsivity on the attentional impulsivity (p 
and nonplanning impulsivity (p < 0.001) subscale
In the ethnically homogeneous group of African American 
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below).  
 
-
< 0.001), 
 
subjects only, BIS-11 total (p < 0.001) attentional (p
0.001) were significantly higher, but groups
motor subscale scores, although this was still a trend (p
 
 
Figure 8: BIS-11 Results
than controls in both the BIS total and subscale scores. 
 
We observed different genetic associations for different blocks of the Cocaine 
Stroop task. For the average attentional bias score (both blocks of the task combined) 
we observed an association with 
observed an effect when examining genotype groups for 
second block an association with 
We hypothesized that variants associated with lower serotonin function would 
be associated with higher attentional bias and impulsivity 
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average attentional bias for the Stroop task, and subjects with the C allele had higher 
attentional bias (p = 0.02)(See figure 8).  
 
 
 
Figure 9: The 5-HT2C Variant and attentional bias: The C allele for the HTR2C 
gene was associated with higher average attentional bias in cocaine dependent 
subjects.  
 
To study the relationship between serotonin transporter function and 
attentional bias, we analyzed genotype and allele groups for the 5-HTTLPR variant 
and Stroop Task performance scores. For the two different allele groups (see figure 
below), we divided subjects into two genotype groups: the L' group which included 
the LA/LA genotype and the S' group which was comprised of the LA/ LG, LA/ S, 
LG/LG, LG/S and S/S genotypes.  The latter group is also referred to as the S-carriers, 
because these individuals are likely to have low transporter function. There was a 
significant difference in attentional bias for the first block of the task between 5-
HTTLPR L' and S' genotypes, with the S' genotype exhibiting higher attentional bias 
(p = 0.04).  
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Figure 10: 5-HTTLPR genotype groups and attentional bias: Cocaine dependent 
individuals who were S-carriers for the 5-HTTLPR displayed higher attentional bias 
scores for the first block for the first block of the Cocaine Stroop Task.  
 
Tryptophan hydroxylase plays an important role in serotonin synthesis, as the rate 
limiting enzyme. For this reason, we hypothesized that tryptophan hydroxylase 
variants might be associated with higher attentional bias and impulsivity. The variant 
for TPH2 that we chose to study is SNP rs4390270, which has shown association 
with addiction-related disorders in the literature. A significant difference between 
TPH2 genotype groups was observed for the second block of the Cocaine Stroop 
Task. We observed a significant difference between both TPH2 genotypes and alleles 
in attentional bias scores (p = 0.03 and p = 0.01, respectively) with the TT genotype 
displaying the highest attentional bias for cocaine-related words.  
 
 
-20
0
20
40
60
80
100
120
140
160
LL S
A
tt
e
n
it
o
n
a
l 
B
ia
s 
B
lo
ck
 1
5-HTTLPR
L'L'   L'S'+S'S' 
33 
 
 
 
Figure 11: The TPH2 Variant and attentional bias: For the second block of the 
Cocaine Stroop Task, cocaine dependent individuals with the TT genotype displayed 
the highest attentional bias scores.  
 
          We also hypothesized that there would be a relationship between serotonin 
transporter variants and self-report impulsivity scores in cocaine dependent 
individuals. We analyzed BIS-11 scores for different genotype and allele groups of 
the 5-HTTLPR. In African Americans, there was a significant difference between 5-
HTTLPR genotypes in scores for BIS total and attentional impulsivity (p= 0.03, p= 
0.02 respectively). Unlike the results for attentional bias, it was the L' genotype that 
showed association with higher attentional impulsivity.  
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Figure 12: 5-HTTLPR genotype groups and impulsivity
who were classified to be in the L genotype group displayed higher BIS
impulsivity scores than the individuals in the S genotype group. 
 
We did not theorize on different relationships between 
groups and impulsivity scores for cocaine users versus healthy controls. In our study 
sample, however, we did observe such a converse relationship. 
ethnicity group, there was a significant interaction between 
BIS attentional impulsivity
No significant effects were observed in either the mixed or African American control 
group. The power for the sample was calculated to be 0.58 for a one way ANOVA. 
Figure 13: 5- HTTLPR genotypes and Impulsivity
observed for genotype groups and Attentional Impulsivity subscale scores of the BIS
11 in cocaine versus control subjects. 
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6 – DISCUSSION  
 
          The purpose of this study was to investigate the role of variants in genes of the 
serotonin system in attentional bias and impulsivity in cocaine dependent individuals. We 
focused on several genes in the serotonin system, including the serotonin transporter, 
those coding for the serotonin receptors 2A and 2C and tryptophan hydroxylase 1 and 2. 
We predicted that attentional bias and impulsivity would be higher in cocaine dependent 
individuals who had lower serotonin function.  
 
Serotonin Receptor 2C 
 
          There was a significant difference between 5-HT2C receptor genotypes in 
attentional bias in our study sample. In preclinical studies, 5-HT2C agonists reduce 
responses to cocaine cues in rats (Nic Dhonnchadha, Fox et al. 2009) . Variants in the 
HTR2C gene have been associated with attention deficit hyperactivity disorder, 
schizophrenia, bipolar disorder, obesity in psychiatric patients, and other psychiatric 
disorders (Berg, Clarke et al. 2008; Drago and Serretti 2009). These data suggest that the 
2C receptor may be involved in not only psychiatric disorders, but also impulse control. 
In the present study we genotyped subjects for the rs6318 Cys23Ser variant of the 
HTR2C gene, which has been shown to be associated with eating disorders and unipolar 
and bipolar affective disorders, reviewed in (Drago and Serretti 2009).  Interestingly, this 
variant has also been associated with co-morbid bipolar disorder and alcoholism 
(Yasseen, Kennedy et al. 2010) Also, a study looking at monoamine metabolite 
concentrations in a male population that included alcoholic violent offenders and 
controls, found that the polymorphism contributes to variation of CSF 3-Methoxy-4-
hydroxyphenylglycol (MHPG), a norephinephrine metabolite, with the Ser variant 
leading to higher levels of the metabolite, and the authors suggested that the Ser variant is 
less responsive to released serotonin (Lappalainen, Long et al. 1999). When cells are 
treated with inverse 5-HT2C agonists, the Ser variant displays different desensitization 
responses than the Cys variant (Okada, Northup et al. 2004).    
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          Our findings were that the Ser variant leads to higher average attentional bias in the 
cocaine dependent group, and this is in not in agreement with the preclinical literature 
(Filip and Cunningham 2002; Liu and Cunningham 2006). Perhaps, like Lappalainen et al 
suggested, the cocaine dependent individuals with the Ser variant are less responsive to 
released serotonin, due to different desensitization properties of the receptors. Also, it is 
possible that in cocaine dependent individuals, an increase in serotonin may take place 
after cocaine exposure and the desensitization properties of the receptor might come into 
play. Therefore, when serotonin is increased in the synapse, it doesn’t have the agonist 
effects that have been associated with reduction of cue reactivity in animal experiments. 
 
Serotonin Transporter  
 
          The current study yielded several significant results when we analyzed the 5-
HTTLPR data. Due to inconsistency in the literature in genotyping 5-HTTLPR, we 
performed analysis by considering the internal SNP that influences the 5-HTTLPR’s 
function (triallelic method, (Hu, Lipsky et al. 2006) and not considering it (biallelic 
method). For the triallelic analysis, there was a significant difference between 5-HTTLPR 
genotypes in average attentional bias in cocaine dependent individuals (mixed ethnicity 
group). In the ethnically homogenous African American group of cocaine dependent 
individuals, when we analyzed attentional bias scores for the first block of the Stroop task 
there was a significant difference between 5-HTTLPR genotypes when individuals were 
grouped for the presence of the lower functioning variant (L'L' vs L'S' + S'S'), as has 
commonly been done in previous literature (Patkar, Berrettini et al. 2002). For the bialleic 
analysis, significant effects were observed, although these were all in the control group. 
Additionally, there was a significant difference between 5-HTTLPR genotypes in BIS 
total and attentional impulsivity subscale scores. 
          The serotonin transporter is important in that it controls synaptic levels of serotonin 
by pumping serotonin molecules back into the presynaptic neuron after they have been 
released, and essentially refreshing the synapse after action potential activity. The 
functional variant that we studied has been associated with both behavioral and 
psychiatric disorders, although findings have been inconsistent. The transporter is 
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expressed in cortical and limbic areas that process emotional components of behavior 
(Lesch, Bengel et al. 1996). For this reason, the serotonin transporter is also thought to 
act on emotional regulation, impulsivity and anxiety as a function of specific contexts 
(Courtet, Jollant et al. 2005). S-carriers, individuals possessing at least one S allele, have 
also displayed more anxiety-related traits compared to LL individuals in a large study of 
healthy volunteers (Lesch, Bengel et al. 1996). S carriers have also been reported to score 
lower for coping ability on an emotional appraisal questionnaire, and the investigators 
have classified S carriers as being cognitively vulnerable (Szily, Bowen et al. 2008). A 
study examining the role of 5-HTTLPR genotype and the influence of framing in decision 
making found a significant association between the SS genotype and greater amygdala 
activation while making decisions inside a functional magnetic resonance imaging 
(fMRI) scanner (Roiser, de Martino et al. 2009).  
          Transporter genotype has also been associated with acquisition of fear 
conditioning, and S-carriers show better acquisition (Garpenstrand, Annas et al. 2001). In 
healthy individuals, carriers of the S allele have been reported to perform better on the 
Wisconsin Card Sorting Test, a measure of executive function, compared to LL 
individuals (Borg, Henningsson et al. 2009). Although previous studies have yielded 
inconsistent findings regarding cognitive performance and the 5-HTTLPR, it may be 
possible that cocaine dependent individuals who are S carriers experience greater limbic 
activation when they encounter cocaine-related cues and this process contributes to 
greater attentional bias on the cocaine Stroop task.  
          Studies investigating the role of the 5-HTTLPR in drug dependence have been 
contradictory and inconsistent. In a study examining serotonin transporter variants in 
several populations of different geographic origins, there was no association between 5-
HTTLPR alleles and alcohol dependence (Gelernter, Kranzler et al. 1997). Kremer et al 
2005 found the L allele to be more abundant in smokers (Kremer, Bachner-Melman et al. 
2005). Mannelli et al. examined the serotonin transporter gene in African American 
cocaine and alcohol-dependent individuals and found that people who carried the S allele 
had greater severity of alcohol use at admission and showed less improvement after 
treatment at follow-up (Mannelli, Patkar et al. 2005). Enoch et al found that the low 
activity form (S allele) was more common in a group of African American patients with 
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addiction compared to controls (Enoch, Gorodetsky et al. 2010) Another study reported 
that the LL genotype was higher in cocaine-dependent individuals, suggesting the long 
form of the transporter to be an addiction vulnerability variant. This difference was not 
significant when they limited their group to African Americans only, however (Patkar, 
Berrettini et al. 2001). Interestingly, one group investigating alcoholism, found that the L 
allele is associated with increased craving for alcohol at the beginning of alcohol 
withdrawal (Bleich, Bonsch et al. 2007). These last reports are in agreement with our 
findings.  
         We observed a difference in genotype frequencies of the 5-HTTLPR between 
cocaine dependent individuals and control subjects when analyzing the total group, which 
was ethnically heterogeneous. When we restricted the group to those of African 
American ethnicity, this genotypic difference was not significant, but the allele frequency 
was different between the two groups. The L allele was more abundant in the cocaine 
dependent individuals.  
          The purpose of this study was to investigate the relationship between 5-HTTLPR 
genotype and behavior in cocaine dependent users. The hypothesis was that there is a 
gene-environment interaction: cocaine dependent users with the L allele display the most 
attentional bias and impulsivity. We found that in cocaine dependent individuals, the SS 
individuals showed the highest attentional bias, while in the healthy control group the SS 
individuals showed the lowest attentional bias. Although we expected the attentional bias 
scores to be close to zero for the control subjects, this was not the case. Within this group 
there were subjects that had scores that resembled those in the cocaine group and subjects 
who had negative scores (indicating they were biased towards the neutral words). This 
could be due to experimental error or the controls in our sample were not honest about 
past cocaine use. These findings need to be replicated, due to the small sample size of our 
study and uneven genotype groups.  
 
Tryptophan Hydroxylase 2 
 
          In the current study, we found a significant difference in attentional bias for the 
second block of the cocaine Stroop task between TPH2 SNP rs4290270 genotypes. 
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Individuals with the TT genotype displayed the highest attentional bias scores. The TPH2 
gene has been reported to be critical in controlling serotonin levels in the brain (Dahl, 
Cubells et al. 2006). It has been the focus of many studies of psychiatric and addictive 
disorders. Zill et al reported an association between TPH2 variants and major depression 
(Zill, Baghai et al. 2004). For the SNP we studied, although not many researchers have 
investigated its functional role, one study has identified that it may have functional 
effects and another has implicated that the T allele is associated with higher function 
(Lim, Pinsonneault et al. 2007; Roche and McKeon 2009).  
     More studies need to be performed to evaluate rs4290270’s functional role before 
we can confidently theorize on the SNP’s influence. However, if the studies mentioned 
above are accurate, our data indicate that perhaps higher TPH2 function, which may lead 
to higher levels of serotonin being produced, is negatively affecting attentional bias in the 
cocaine dependent subjects. A recent publication reported altered levels of serotonin 
metabolites in cocaine dependent individuals compared to healthy controls (Patkar, 
Rozen et al. 2009). Because the TPH2 variant we genotyped was associated with the 
largest effect in attentional bias in our sample of cocaine dependent individuals, we 
hypothesize that this gene may be a critical component in the alterations in tryptophan 
metabolism and this is in agreement with the data observed by Patkar et al. Even though 
the genotype associated with attentional bias in cocaine dependence may be producing 
more TPH2 enzyme, which in turn would increase serotonin production, this modulation 
in the system may change the synaptic dynamics by leading to modifications in pre and 
post-synaptic receptors that may lead to more attentional bias. This variant could be 
creating functional differences by splicing, altered binding to enhancers and repressors, 
etc.  
          Studies that have focused on other TPH2 variants that cause functional effects on 
the gene product, have found an association with depression (Zhang, Gainetdinov et al. 
2005).  TPH2 genetic variants have been associated with affective disorders and bipolar 
disorder, as well (Harvey, Shink et al. 2004; De Luca, Likhodi et al. 2005). These results 
may be relevant to the present study because a high rate of mood disorders in individuals 
who use cocaine (abuse or dependent) has been reported (Rounsaville 2004). Reduced 
function in the TPH2 enzyme may be a common feature of the pathophysiology of mood 
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disorders, impulsivity and cocaine addiction. In genetic vulnerability studies, however, 
TPH2 has not always yielded positive findings. Dahl et al studied six variants in the 
TPH2 gene that were in linkage disequilibrium with the more commonly studied variants 
(specifically rs7963717, rs1386495, rs4760816, rs1007023, rs1386486 and rs1872824) 
and did not find an association with the cocaine-dependent phenotype for an ethnically 
similar (African American) group of cocaine dependent individuals (Dahl, Cubells et al. 
2006).  
     We did not observe an effect of the TPH2 variants on self-reported impulsivity, 
and this is not consistent with other studies that have reported an association between 
TPH2 gene variants and impulsivity. Stoltenberg et al. found an association between the 
TT genotype in variant rs1366483 and a longer response inhibition time in the Stop Task 
in a healthy male population (Stoltenberg, Glass et al. 2006). Another group found an 
association between the TT genotype of a TPH2 -703 G/T polymorphism and errors on 
an executive control attention task (Reuter, Ott et al. 2007). Perhaps behavioral measures 
of impulsivity are more sensitive than self report scores, or the cocaine dependence made 
the difference between previously reported results and our sample’s outcome.  
 
Serotonin Receptor 2A 
 
          We found a trend between the 5-HT2A receptor TT genotype and increased 
attentional bias in the cocaine dependent group. These individuals also had higher self-
reported impulsivity scores.  Studies show that mRNA for the 2A receptors is most 
abundant in the frontal cortex (Pompeiano, Palacios et al. 1994). The 5-HT2A receptor has 
been associated with impulsivity: lower receptor density has been observed in impulsive 
and violent aggressive individuals (Meyer, Wilson et al. 2008). In preclinical studies, 5-
HT2A receptor antagonists have been associated with decreasing cue-reinstated behavior 
in rats. Blocking the 2A receptors attenuates the locomotor response that’s induced by 
cocaine (Fletcher, Grottick et al. 2002). The authors suggested that 2A receptor blockade 
modulates locomotor-stimulant properties of cocaine but not the reinforcing effects of the 
drug (Fletcher, Grottick et al. 2002). In our results we did not observe a difference in 
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motor impulsivity between the genotypes, but perhaps if the sample was larger we would 
be able to observe an effect.   
          An inverse relationship between 5-HT2A receptor density and serotonin levels have 
been implicated by the literature. Lower CSF 5-HIAA has been observed in people with 
aggressive and impulsive behavior (Brown, Ebert et al. 1982). Increased 5-HT2A receptor 
density however has been associated with reduced reactivity to threat related stimuli. 
Fisher et al. measured receptor binding using PET and BOLD activation using fMRI in 
the amygdalas of healthy volunteers (Fisher, Meltzer et al. 2009). The authors suggested 
that serotonin plays a role in integrating affective information between amygdala and 
prefrontal cortex, with the 2A receptor being predominant in this modulation (Fisher, 
Meltzer et al. 2009).  While 5-HT2A receptor mRNA is concentrated in several brain 
areas, mRNA for the 2C receptor is more widespread in the CNS, and almost excusively 
in the central nervous system (Pompeiano, Palacios et al. 1994). Li and colleagues 
studied alterations in 5-HT2A and 5-HT2C receptors in serotonin transporter knockout 
mice (Li, Wichems et al. 2003). They found changes in the density of both receptors, 
with region- specific alterations. The 2A receptors were increased in hypothalamus and 
septum and decreased in the striatum while the 2C receptors were increased in the 
amygdala (Li, Wichems et al. 2003). The T allele is associated with higher expression of 
the 2A receptor and perhaps, in our sample, this correlated with reduced serotonin 
function (Polesskaya and Sokolov 2002).  The functional effects of the T allele could be 
due to differential splicing, increased binding of enhancers or similar mechanisms that 
would lead to higher gene expression . 
 
Tryptophan Hydroxylase 1 
 
          TPH1 has been a vulnerability gene for suicidality, and has been thought to be 
involved in suicidal behavior, especially violent suicide attempts (Mann, Malone et al. 
1997; New, Gelernter et al. 1998; Nielsen, Virkkunen et al. 1998; Abbar, Courtet et al. 
2001; Courtet, Jollant et al. 2005). Many variants have been identified in the gene, with 
several associations found relating TPH1 and alcoholism, nicotine dependence, antisocial 
behavior and heroin addiction, (Nielsen, Goldman et al. 1994; Nielsen, Barral et al. 2008; 
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Nielsen, Ji et al. 2008; Yuferov, Levran et al. 2010). We did not find any significant 
association between genotypes of TPH1 when we analyzed attentional bias and self-
report impulsivity scores. Perhaps TPH1 is not related to behavioral aspects of drug 
dependence that involve prefrontal cortex or top-down processing. TPH1 plays an 
important role in central nervous system development but it may not be important to 
brain areas involved in executive functioning or sensory processing simply due to 
anatomical localization (TPH2 on the other hand would be hypothesized to play a larger 
role here).  
   
Summary of genetic results 
 
          We observed significant findings for HTR2C, 5-HTTLPR and TPH2 variants. The 
HTR2C Cys23Ser SNP was observed to make a difference in average attentional bias 
scores of cocaine-dependent individuals. This implies that HTR2C is associated with a 
general attentional bias effect in the Cocaine Stroop task.  
          The 5-HTTLPR, on the other hand, showed an effect on performance in the first 
block of the task, which was also when all subjects displayed the highest attentional bias 
scores. We hypothesize that this first part of the task relates to attentional impulsivity, 
although, this was not observed in the data.  The 5-HTTLPR results suggest that synaptic 
serotonin levels (modified by the serotonin transporter) might be related to the processes 
responsible for the interference that cocaine-related words exert on color naming. S-
carriers had the highest attentional bias scores for the first block of the Cocaine Stroop 
task, but it was the other genetic group, the L'L' individuals, that had significantly higher 
attentional impulsivity scores. These results suggest that the serotonin transporter or 
synaptic serotonin levels might play different roles in attentional bias and impulsivity. 
There was no correlation between attention bias scores for the first block of the task and 
BIS attentional impulsivity, suggesting that the two tasks measure different constructs, 
and serotonin transporter function exerts differential effects on attentional bias and 
impulsivity.  
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          We also observed an interaction effect between 5-HTTLPR genotype and BIS 
attentional impulsivity in our study sample. This interaction effect might be indicative of 
a gene environment interaction. Individuals with the L´L´ genotype who were cocaine 
users displayed the highest BIS attentional impulsivity scores. On the other hand, it was 
controls with the S´S´ genotype that displayed the highest attentional impulsivity scores. 
Cocaine directly interacts with the serotonin transporter, and could have caused this 
difference in impulsivity between controls and cocaine-dependent individuals, increasing 
attentional impulsivity in individuals who perhaps had lower scores before cocaine use.  
          Lastly, for the TPH2 variant we studied, individuals with the TT genotype 
displayed the highest attentional bias scores for the second block of the task. During the 
second block, the attentional bias scores were generally reduced for all subjects. We 
hypothesize that this block of the task represents learning or an extinction effect. Subjects 
who continue to display high attentional bias in this last block of the task might be 
experiencing reduced capacity to learn. On the other hand, the second block of the task 
could be representing a completely different and separate process that subjects experience 
while performing the task.  
 
Therapeutic implications 
 
          In agreement with recent preclinical findings, the current study suggests that 
serotonergic medications may be utilized as pharmacotherapeutic treatment for cocaine 
addiction. Our results indicate that the serotonin transporter, 2C receptor and tryptophan 
hydroxylase 2 should be targeted. There are several FDA approved pharmacological 
treatments that target these systems already, for example, selective serotonin reuptake 
inhibitors (SSRIs) target the serotonin transporter. Our study results suggest that 
increasing serotonin transporter function will reduce attentional bias. Some other possible 
therapeutic agents might be partial 5-HT2C receptor agonists, such as meta-
Chlorophenylpiperazine (mCPP). Serotonin receptor agonists however, might lead to 
different treatment responses for different genetic backgrounds.  
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Limitations 
 
          One limitation of this study is the sample size. The control group was too small. In 
the total African American group, if the sample sizes were larger, there would likely 
more significant findings. The present study was only on average, 0.50 powered to detect 
an association between serotonin variant genotypes and attentional bias or self-reported 
impulsivity in cocaine dependent individuals. This low power is due to the small number 
of subjects in the study. We expect that if we were to increase the sample size (essentially 
double it), the study would be .80 powered to have detect a p < 0.05 significant 
difference.  
          In addition, the case and control populations have different age and sex 
compositions. It’s possible that the results in the study are confounded by these age and 
sex differences. For HTR2C, especially, which is found on the X chromosome, we would 
expect sex differences. However, when we covaried for age or sex, we did not find a 
difference in the results. Subsequent studies could examine genetic variation of these 
genes in larger, better selected populations of cocaine-dependent individuals and control 
subjects. Restricting the age range to make sure that age in the study sample is not 
responsible (a confounder) for cognitive performance would be beneficial. In future 
studies, it would also be beneficial to recruit an equal number of subjects with specific 
genotypes for HTR2A and HTR2C as well as TPH1 and TPH2 to participate. This was not 
done in the current study.  
        For behavioral testing, the picture version of the cocaine Stroop Task could be 
administered to reduce inter-trial variability for the subjects and reduce the variance in 
response. Pictures might provide stimuli that are closer to the environmental triggers that 
subjects are exposed to in nature. We observed the biggest attentional bias difference 
between the cocaine and control groups in the first block of the Cocaine Stroop task. 
Before the subjects performed this block of the task, they completed 60 practice trials. In 
the future, we can also record subject responses during the practice trials to see if the 
attentional bias is even higher at this earliest stage. Dividing the task in more blocks 
might also be beneficial in allowing us to analyze learning processes that might take 
place in the progression of the task.  
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         Early studies using variations of the Stroop task observed an effect for therapy. For 
example, patients with depression showed a greater response latency in naming the color 
of words associated with depressive symptoms compared to neutral and positive words. 
When these patients were tested again after therapy and clinical improvement, they did 
not display this difference in performance (Gotlib and Cane 1987). Similar results were 
observed in patients with specific phobias and anxiety  (reviewed in  (Williams, Mathews 
et al. 1996). Perhaps in future studies, we can test subjects before and after they undergo 
treatment. This way we can investigate the role of serotonin genetics and treatment on 
attentional bias scores in cocaine dependent subjects.  
          In animal models, the serotonin transporter is reported to interact with the products 
of other genes, including ones encoding serotonin receptors, other neurotransmitter 
systems and neurodevelopmental proteins (Homberg, Nijman et al. 2010) Serotonin 
transporter knockout mice provide a low transporter activity model that is similar to 
cocaine use. We may choose to focus on other variants that have been reported to be in 
linkage disequilibrium with the 5-HTTLPR. For example,  it’s been reported that 
individuals with a low 5-HTTLPR variant and a gain of function 5-HT3 receptor variant 
were 2.5 more likely to be diagnosed with alcohol and drug dependence  (Enoch, 
Gorodetsky et al. 2010) In future studies, we may study this variant.  
          Another aspect of genetic variation that needs to be addressed is the possibility that 
observed changes are due to epigenetic mechanisms, such as DNA methylation, histone 
modifications and miRNA. A complex fine-tuning of neurotransmitters occurs in the 
central nervous system and individuals with different genetic backgrounds all undergo 
adaptations that establish a homeostatic level of functioning. Epigenetic changes, 
however, might reflect more recent changes in gene regulation which might be better 
suited to extrapolation due to environmental exposures such as cocaine.  
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7 – CONCLUSIONS 
 
          Our results suggest that the serotonin system is related in the modification of 
attentional bias, and to a lesser extent, impulsivity in this population of cocaine 
dependent subjects. The data collected for this thesis did not support our hypothesis 
regarding variants that lead to lower serotonin function also lead to higher attentional bias 
and impulsivity. For the genetic variants in which we observed significant differences, 
our data supported the opposite relationship. Variants that led to higher serotonin 
function increased attentional bias.   
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